DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pjxkvt/research_and) has announced the addition of the "Research and Investment Forecast Evaluation of China's Enteral Nutrition Preparation Market from 2015 to 2020" report to their offering.
In recent years, with the popularization of clinical nutrition conception in China, more and more domestic enterprises set foot in this field. According to statistics, in 2010, the market scale of enteral nutrition preparation was CNY 2.21 billion in China, by the end of 2014, it was CNY 4.11 billion and increases continually.
Overall, at present, the clinical nutrition is still in development stage in China, the home-made clinical nutrition preparations still far lag behind overseas level in respects of both quality and variety, the high-grade product market is monopolized by the imported or joint-venture products. With the constant upgrades of clinical academic concepts, from the original intravenous hyperalimentation, to equal nitrogen, equal thermal treatment, to low nitrogen, low calorie parenteral nutrition solution, to enteral nutrition and to joint nutrition treatment theory. The emphasis in now on higher requirements on convenience and safety of clinical nutrition products. A new trend is the emergence of infusion method of "All-in-one" nutrient solutions. Parenteral nutrition should give the most reasonable infusion method, become common sense clinically.
Companies Mentioned
- Netherlands Nutricia
- Sino-Swed Pharmaceutical Corp, Ltd. (SSPC)
- Abbott Laboratories
- NOVARTIS Pharmaceutical Co.,Ltd
- Xi'an Libang Clinical Nutrition Limited Company
For more information visit http://www.researchandmarkets.com/research/pjxkvt/research_and
